J. Xu

Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma

Background The Cholangiocarcinoma treatment options are constantly being updated in view of existing evidence in order to establish practice guidelines and consensus sta...

M. Abdelrahim ;

A. Esmail ;

A. Saharia ;

J. Xu ;

G. Umoru ;

H. Al-Rawi ;

06/27/2022

Featured CME

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

May 28 ⁠–⁠ May 31

See Full Calendar

J. Xu

Featured CME

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products